|
The inner guiding catheter was not separated from the pushing catheter(outer, color is purple) when the stent was tried to be placed in the bile duct.They re-started stent placed procedures, placed the other stent on the bile duct, and finished the procedure.(the stent used is unknown).Did any section of the device remain inside the patient body? no.Did the patient require any additional procedures due to this occurrence? no.Did the product cause or contribute to the need for additional procedure(s)? no.Were there any adverse effects on the patient due to this occurrence? no.Did the product cause or contribute to the adverse effect(s)? no.Please indicate where the device was stored prior to use.This product was located in the ercp room prior to use.What is the reorder number, outer diameter and length of the wire guide that was used with this device in this procedure? visiglide 2 guidewire - outer diameter 0.025in / length 450cm / tip shape angled / first use.Were previous procedures i.E.Sphincterotomy etc.Carried out prior to placing the device over the particular wire guide? if yes please indicate the procedure performed.Sphincterotomy.Was the wire guide inspected for damage prior to use? yes, it was.Was the device at the centre of the complaint inspected for damage prior to use? yes, it was.Did the patient involved exhibit altered anatomy or tortuous anatomy? no.If not with the device in question, how was the procedure finished? they re-started stent placed procedures, placed the other stent on the bile duct, and finished the procedure.(the stent used is unknown).For complaints occurring during use (once in contact with endoscope) also ask: had a sphincterotomy been performed prior to this occurrence? yes, they had.What is the endoscope manufacturer, the model number and working channel size that was used for the procedure? olympus tjf260v, 4.2mm.Does your medical facility have a service/maintenance schedule associated with its endoscopes? unknown.Please indicate the location in the body where the stent device was to be placed.(i.E.Biliary duct, pancreatic duct, other).The bile duct.Was resistance encountered when advancing the wire guide to the target location? no.Was the stricture dilated prior to placing the device? if so, please indicate what device(s) were used.Unknown.Was resistance encountered when advancing the introduction system in place to the target location? no.Was resistance encountered when advancing the stent through the obstructed area?n/a (mark n/a if device was not used on any patient) after placement, was stent position verified? if yes, please describe how.No.Please estimate/indicate the amount of time the stent was in place dwelling prior to this occurrence.Unknown.Did any section of the device detach inside the endoscope or patient? no.
|
|
Device evaluation: 1 x zss-10-10-rb device of lot number cf1707652 involved in this complaint was not returned to cirl for evaluation.Document review: prior to distribution ¿zss-10-10-rb¿ devices are subjected to a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl.A review of the manufacturing records for ¿zss-10-10-rb¿ of lot number ¿cf1707652¿ did not reveal any discrepancies that could have contributed to this complaint issue.The review of relevant manufacturing records confirms the failure mode has not previously occurred with the current lot number.Based on the information available to date, there is no evidence to suggest that there are any manufacturing issues associated with lot number ¿cf1707652¿.It should be noted that the instructions for use (ifu0100) states the following: ¿intended use: ¿to drain obstructed biliary ducts" and in the notes section ¿do not use this device for any purpose other than stated intended use.¿.¿notes: visually inspect with particular attention to kinks, bends and breaks.If an abnormality is detected that would prohibit proper working condition, do not use¿.It may be noted the device label indicates a 0.035¿ wire guide for use with this device and all simulated use testing to date has been completed using a 0.035¿ wire guide.As per information received, it is confirmed that a 0.025" wire guide was used.There is evidence to suggest the user did not follow the ifu.Root cause review: a definitive root cause can be attributed to the use of a non-recommended wire guide with the device.It may be noted the device label indicates a 0.035¿ wire guide for use with this device and all simulated use testing to date has been completed using a 0.035¿ wire guide.As per information received, it is confirmed that a 0.025" wire guide was used.Summary: complaint is confirmed from the customer testimony.According to the information reported, the patient did not experience any adverse effects due to this occurrence.Complaints of this nature will continue to be monitored for potential emerging trends.
|